Abstract
A series of Val-Leu based peptidic aldehydes containing either a furan or thiophene at the Nterminus was prepared and assayed against ovine m-calpain. In general, potency is favoured by a 2- substituted (rather than 3-substituted) heterocycle, a thiophene rather than a furan, and a shorter chain length at the N-terminus. Molecular docking experiments provide some rationale for these observations.
Keywords: Calpain inhibitors, peptidic aldehydes, synthesis, heterocycles
Protein & Peptide Letters
Title: N-Heterocyclic Dipeptide Aldehyde Calpain Inhibitors
Volume: 16 Issue: 12
Author(s): Seth A. Jones, Matthew A. Jones, Stephen B. McNabb, Steven G. Aitken, James M. Coxon and Andrew D. Abell
Affiliation:
Keywords: Calpain inhibitors, peptidic aldehydes, synthesis, heterocycles
Abstract: A series of Val-Leu based peptidic aldehydes containing either a furan or thiophene at the Nterminus was prepared and assayed against ovine m-calpain. In general, potency is favoured by a 2- substituted (rather than 3-substituted) heterocycle, a thiophene rather than a furan, and a shorter chain length at the N-terminus. Molecular docking experiments provide some rationale for these observations.
Export Options
About this article
Cite this article as:
Jones A. Seth, Jones A. Matthew, McNabb B. Stephen, Aitken G. Steven, Coxon M. James and Abell D. Andrew, N-Heterocyclic Dipeptide Aldehyde Calpain Inhibitors, Protein & Peptide Letters 2009; 16 (12) . https://dx.doi.org/10.2174/092986609789839296
DOI https://dx.doi.org/10.2174/092986609789839296 |
Print ISSN 0929-8665 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5305 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Tankyrase as a Novel Molecular Target in Cancer and Fibrotic Diseases
Current Drug Targets Strategies to Improve Bioavailability and <i>In Vivo</i> Efficacy of the Endogenous Opioid Peptides Endomorphin-1 and Endomorphin-2
Current Topics in Medicinal Chemistry The Role of Oxazolidine Derivatives in the Treatment of Infectious and Chronic Diseases
Current Bioactive Compounds Matrix Metalloproteinase Inhibition in Atherosclerosis and Stroke
Current Molecular Medicine The Glioblastoma Problem: Targeting by Combined Medicinal Chemistry Approaches
Current Medicinal Chemistry Modulation of Cellular Function by TAT Mediated Transduction of Full Length Proteins
Current Protein & Peptide Science P2X7 Receptor-Associated Programmed Cell Death in the Pathophysiology of Hemorrhagic Stroke
Current Neuropharmacology PEDF in Angiogenic Eye Diseases
Current Molecular Medicine tPA in the Central Nervous System: Relations Between tPA and Cell Surface LRPs
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Review of the Biological Activity of Maslinic Acid
Current Drug Targets Antiepileptics for Post-Traumatic Seizure Prophylaxis after Traumatic Brain Injury
Current Pharmaceutical Design Potential Phytotherapeutic Approaches for the Treatment of Alzheimer’s Disease: An Overview
Current Traditional Medicine The Neuroprotective Effect of Ginkgo biloba Leaf Extract and its Possible Mechanism
Central Nervous System Agents in Medicinal Chemistry Patent Selections
Recent Patents on Mechanical Engineering Exosomes and Exosomal microRNAs in Age-associated Stroke
Current Vascular Pharmacology New Heterocyclic Compounds: Synthesis, Antioxidant Activity and Computational Insights of Nano-Antioxidant as Ascorbate Peroxidase Inhibitor by Various Cyclodextrins as Drug Delivery Systems
Current Drug Delivery Homology-Based Design for Selective GSK-3 Peptide Inhibitors: Patent Applications and Type 2 Diabetes Mellitus
Current Signal Transduction Therapy Proteasomes as Drug Targets
Current Drug Targets Migraine and Central Sensitization: Clinical Features, Main Comorbidities and Therapeutic Perspectives
Current Rheumatology Reviews Targeting Ionotropic Glutamate Receptors in the Treatment of Epilepsy
Current Neuropharmacology